Results 151 to 160 of about 28,422 (269)

Wells syndrome: clinical findings and treatment management in a large cohort of 48 patients

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 5, Page 644-656, May 2026.
Summary Background and Objectives: Wells syndrome (WS) is a rare inflammatory skin disorder typically characterized by erythematous, edematous, and pruritic plaques. Despite its distinct histopathological features, WS remains an underdiagnosed disease due to its variable clinical presentations and overlap with other dermatological conditions.
Marco Adriano Chessa, Silvia Robuffo, Tullio Brunetti, Luca Rapparini, Bianca Maria Piraccini, Cosimo Misciali, Beatrice Raone, Iria Neri, Federica Filippi   +8 more
wiley   +1 more source

Omalizumab in the management of patients with allergic (IgE-mediated) asthma

Journal of Asthma and Allergy, 2009
Thomas SandströmDepartment of Respiratory Medicine and Allergy, University Hospital, Umeå, SwedenAbstract: Immunoglobulin E (IgE) is central to the pathophysiology of allergic asthma.
Thomas Sandström
doaj  

Feasibility and Patient Experiences in a WhatsApp‐Based Educational Pilot for Spanish‐Speaking Adults With Chronic Spontaneous Urticaria

International Journal of Dermatology, Volume 65, Issue 6, Page 1285-1287, June 2026.
Elise Edwards, Carlos Lange Nava, Jemima Constanza, Alison Tran, William Abramovits, Gil Yosipovitch   +5 more
wiley   +1 more source

Preliminary Clinical Outcomes of Human Umbilical Cord Mesenchymal Stem Cell‐Derived Exosomes in Chronic Rhinosinusitis With Nasal Polyps: A Case Report

Journal of Cellular and Molecular Medicine, Volume 30, Issue 9, May 2026.
ABSTRACT Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) is a persistent inflammatory disease that may be resistant to medical management and recurs with traditional surgery. We report a 28‐year‐old male with a history of CRSwNP with comorbid asthma, who was resistant to all medical management, including saline irrigation, intranasal corticosteroids (
Manoochehr Avatef‐Fazeli, Gelavizh Rostaminasab, Iman Janghorban Esfahani, Amir Barimani, Kamran Mansouri   +4 more
wiley   +1 more source

Characteristics and outcomes of patients with pediatric‐onset non‐mastocytosis mast cell activation disorders: A CEREMAST study

Pediatric Allergy and Immunology, Volume 37, Issue 5, May 2026.
Abstract Background Mast cell (MC) activation (MCA) disorders (MCAD) include diseases in which MCs excessively release mediators leading to recurrent manifestations of MCA. MCAD encompasses MCA syndrome (MCAS) which is defined by (i) documented systemic symptoms of MCA, (ii) a 20% increase in serum tryptase level from the individual's baseline plus 2 ...
M. Weiss, J. Rossignol, F. Campeotto, E. Foy, C. Elbany, L. Jaume, L. Geroux, O. Debeaupuis, A. Neuraz, L. Bekel, G. Lezmi, N. Bellon, C. Méni, C. Livideanu, M. Madrange, D. Condé, J. Agopian, C. Michot, F. Villard‐Truc, A. Lachaux, C. Greco, S. Hadj‐Rabia, P. Dubreuil, O. Hermine, C. Bodemer, L. Polivka   +25 more
wiley   +1 more source

Estudio de utilización de omalizumab y mepolizumab en asma refractaria grave [PDF]

, 2018
Introducción. En los últimos años, se han comercializado diferentes fármacos biológicos dirigidos a dianas específicas del asma, como el omalizumab y mepolizumab.
López Cárdenas, Mª Teresa
core  

TREatment of ATopic eczema (TREAT) Registry Taskforce: consensus on how and when to measure the core dataset for atopic eczema treatment research registries. [PDF]

, 2019
BackgroundComparative, real-life and long-term evidence on the effectiveness and safety of phototherapy and systemic therapy in moderate-to-severe atopic eczema (AE) is limited.
Apfelbacher, CJ, Arents, BWM, Barbarot, S, Bosma, AL, Deleuran, M, Eichenfield, LF, Flohr, C, Gerbens, LAA, International TREAT Registry Taskforce, Irvine, AD, Manca, A, Middelkamp-Hup, MA, Schmitt, J, Spuls, PI, Vermeulen, FM, Vestergaard, C, Wall, D, Weidinger, S   +17 more
core  

Long-term outcomes of bronchial thermoplasty in subjects with severe asthma: A comparison of 3-year follow-up results from two prospective multicentre studies [PDF]

, 2017
Bansal, Sandeep, Chupp, Geoffrey, Cohn, Lauren, Grubb, G. Mark, Khatri, Sumita, Kline, Joel N, Laviolette, Michael, McEvoy, Charlene, McMullen, Edmund, Shifren, Adrian, Strauven, Racho   +10 more
core   +2 more sources

The role of omalizumab in the treatment of adults with severe allergic asthma

Zdravniški Vestnik, 2013
Backg round: Omalizumab is a recombinant humanized anti-IgE antibody. It has been used in the treatment of severe allergic asthma since 2007 in Slovenija.
Sabina Škrgat Kristan
doaj  

Isolated Mast Cell–Mediated Angioedema: Clinically Different but Endotypically Similar to Chronic Spontaneous Urticaria

Clinical &Experimental Allergy, Volume 56, Issue 5, Page 562-564, May 2026.
Thomas Buttgereit, Claudia Hayford, Carolina Vera Ayala, Sherezade Moñino‐Romero, Yi‐Kui Xiang, Pavel Kolkhir, Carolin Steinert, Denise Freier, Markus Magerl, Jörg Scheffel, Karsten Weller   +10 more
wiley   +1 more source